Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: Further improvements in treatment outcome

1. Sanz, M.A.
2. Montesinos, P.
3. Rayón, C.
4. Holowiecka, A.
5. De La Serna, J.
6. Milone, G.
7. De Lisa, E.
8. Brunet, S.
9. Rubio, V.
10. Ribera, J.M.
11. Rivas, C.
12. Krsnik, I.
13. Bergua, J.
14. González, J.
15. Díaz-Mediavilla, J.
16. Rojas, R.
17. Manso, F.
18. Ossenkoppele, G.
19. González, J.D.
20. Lowenberg, B.